Skip to main content
Back to Accel

Accel's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by Accel. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$123.6M

Therapeutics Portfolio Companies (4)

Export
BiotechnologyHealth CareMedicalTherapeutics

Syantra is a precision biotechnology company that transforms cancer detection and treatment.

Calgary, Canada
September 2025
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Automera focuses on a novel therapeutic methods to develop drugs.

Singapore, Singapore
September 2023
$16.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareInformation TechnologyInsuranceMental HealthTherapeutics

Headway builds a mental healthcare system that enables therapists to accept insurance and scale their practices.

New York, United States
July 2024
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.

Reims, France
July 2024
$7.6M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Explore Accel's Full Portfolio

View all companies funded by Accel across every industry and funding stage.

View Full Accel Portfolio